無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の整形外科用代替骨移植片市場の分析

US Market Report for Orthopedic Bone Graft Substitutes 2017 - MedCore

発行 iData Research Inc. 商品コード 454932
出版日 ページ情報 英文 589 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.25円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の整形外科用代替骨移植片市場の分析 US Market Report for Orthopedic Bone Graft Substitutes 2017 - MedCore
出版日: 2017年03月01日 ページ情報: 英文 589 Pages
概要

当レポートでは、米国における整形外科用骨移植片の市場について分析し、全体的な市場規模の動向見通し (販売量・収益額・平均価格、市場成長率など) や、材料別・症状別の詳細動向、主な市場促進・抑制要因、近年の資本取引・市場競争動向、企業別の市場シェアなどを調査すると共に、市場の全体的傾向 (疾患・製品の概要、処置件数、治験動向ほか) に関する情報も取りまとめてお届けいたします。

エグゼクティブ・サマリー

米国の整形外科用バイオマテリアル (生体材料) 市場:概略

競争分析

市場の傾向

市場の発展

処置件数

分析対象市場

主要分析の更新状況

過去のバージョン

分析手法

  • 分析範囲
  • IDATAの9段階の分析方法

疾患概要

  • 基本構造
    • 骨格・筋骨格系
  • 疾患の症状・障害
    • 全般的な診断
    • 骨粗しょう症
    • 変形性関節症(OA)
    • 骨移植処置の指標
    • 軟骨修復の指標
    • 変性円盤疾患(DDD)
  • 患者の人口構造
    • 一般統計データ

製品評価

  • 製品ポートフォリオ
    • 代替骨移植片
  • 規制上の問題とリコール
  • 治験

整形外科用代替骨移植片市場

  • イントロダクション
    • 代替骨移植片の市場規模・処置件数、症状別
  • 市場概要
    • 代替骨移植片の市場規模:材料別
    • 代替骨移植片の市場規模:症状別
  • 市場の分析と予測
    • 代替骨移植片の全体的な市場規模
    • 代替骨移植片市場:材料別
      • 自家移植片市場:全体
      • 自家移植片市場:症状別
        • 脊椎
        • 外傷
        • 大関節再建
        • 足部再建
        • 頭蓋顎顔面 (CMF)
        • 腫瘍
      • 脱塩骨基質 (DBM) 移植片市場:全体
      • DBM移植片市場:症状別
      • 合成移植片市場:全体
      • 合成移植片市場:症状別
    • 代替骨移植片市場:症状別
      • 脊椎
        • 頚椎
        • 胸腰椎
      • 外傷
        • 偽関節
        • 新線骨折
      • 大関節再建
        • 股関節再建
        • 膝関節再建
      • 足部再建
      • 頭蓋顎顔面 (CMF)
      • 腫瘍
  • 市場促進・抑制要因
    • 市場促進要因
      • 自家移植片市場の場合
      • DBM移植片市場の場合
      • 合成移植片市場の場合
    • 市場抑制要因
  • 企業別市場シェア分析

略語一覧

付録:各企業のプレスリリース

図表一覧

目次
Product Code: iDATA_USOB17_MC_BGS

Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.

During an autograft procedure, tissue is harvested from the patient's iliac crest, or possibly the distal femur or proximal tibia, and placed at the injury site. An allograft procedure uses donated cadaveric tissue. A grafting procedure using a bone graft substitute replaces human tissue with a synthetic or metal material. For the purposes of this report, metal replacement materials will be excluded, as they are not considered biomaterials.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

As of 2016, the synthetic bone grafts accounted for the largest portion of the market followed by the demineralized bone matrix (DBM) grafts. Market growth has been supported by the strong adoption of the BMP growth factor market, which is represented by Medtronic's INFUSE® product. Furthermore, the fast growing cellular allograft market has benefited the bone graft substitute market by allowing greater osteogenic properties with the use of stem cells. The recent resurgence of growth in the cheaper allograft material market has pushed DBM prices lower in order to stay competitive.

The synthetic bone graft segment surpassed the DBM segment due to both a higher ASP and stronger unit sales growth in the U.S. market. Synthetic grafts are more commonly used in spinal surgeries rather than applications involving larger volumes, as with fracture repair. These large volume indications are the reason that cheaper options, such as allograft bone, play an important role in the market.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
    • 2.1.1. Osteology and Musculoskeletal System
  • 2.2. DISEASE PATHOLOGY AND DISORDERS
    • 2.2.1. General Diagnostic
    • 2.2.2. Osteoporosis
    • 2.2.3. Osteoarthritis
    • 2.2.4. Indication for Bone Graft Procedure
    • 2.2.5. Indication for Cartilage Repair
    • 2.2.6. Degenerative Disc Disease
  • 2.3. PATIENT DEMOGRAPHICS
    • 2.3.1. General Statistics

PRODUCT ASSESSMENT

  • 3.1. PRODUCT PORTFOLIOS
    • 3.1.1. Bone Graft Substitutes
  • 3.2. REGULATORY ISSUES AND RECALLS
    • 3.2.1. Bone Graft Substitutes
  • 3.3. CLINICAL TRIALS
    • 3.3.1. Bone Graft Substitutes

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

  • 4.1. INTRODUCTION
    • 4.1.1. Units per Procedure by Indication
  • 4.2. MARKET OVERVIEW
    • 4.2.1. Bone Graft Substitute Market by Material
    • 4.2.2. Bone Graft Substitute Market by Indication
  • 4.3. MARKET ANALYSIS AND FORECAST
    • 4.3.1. Total Orthopedic Bone Graft Substitute Market
    • 4.3.2. Bone Graft Substitute Market by Material
      • 4.3.2.1. Total Allograft Bone Graft Substitute Market
      • 4.3.2.2. Allograft Bone Graft Substitute Market by Indication
      • 4.3.2.2.1. Spine
      • 4.3.2.2.2. Trauma
      • 4.3.2.2.3. Large Joint Reconstruction
      • 4.3.2.2.4. Foot Reconstruction
      • 4.3.2.2.5. Craniomaxillofacial
      • 4.3.2.2.6. Oncology
      • 4.3.2.3. Total Demineralized Bone Matrix Market
      • 4.3.2.4. Demineralized Bone Matrix Market with and without Carriers
      • 4.3.2.5. Demineralized Bone Matrix Market by Indication
      • 4.3.2.5.1. Spine
      • 4.3.2.5.2. Trauma
      • 4.3.2.5.3. Large Joint Reconstruction
      • 4.3.2.5.4. Foot Reconstruction
      • 4.3.2.5.5. Craniomaxillofacial
      • 4.3.2.5.6. Oncology
      • 4.3.2.6. Total Synthetic Bone Graft Substitute Market
      • 4.3.2.7. Synthetic Bone Graft Substitute Market by Indication
      • 4.3.2.7.1. Spine
      • 4.3.2.7.2. Trauma
      • 4.3.2.7.3. Large Joint Reconstruction
      • 4.3.2.7.4. Foot Reconstruction
      • 4.3.2.7.5. Craniomaxillofacial
      • 4.3.2.7.6. Oncology
    • 4.3.3. Bone Graft Substitute Market by Indication
      • 4.3.3.1. Spine
      • 4.3.3.1.1. Cervical Spine
      • 4.3.3.1.2. Thoracolumbar Spine
      • 4.3.3.2. Trauma
      • 4.3.3.2.1. Non-Union Trauma
      • 4.3.3.2.2. Fresh Fracture Trauma
      • 4.3.3.3. Large Joint Reconstruction
      • 4.3.3.3.1. Hip Large Joint Reconstruction
      • 4.3.3.3.2. Knee Large Joint Reconstruction
      • 4.3.3.4. Foot Reconstruction
      • 4.3.3.5. Craniomaxillofacial
      • 4.3.3.6. Oncology
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
      • 4.4.1.1. Allograft Bone Graft Substitute Market
      • 4.4.1.2. Demineralized Bone Matrix Bone Graft Substitute Market
      • 4.4.1.3. Synthetic Bone Graft Substitute Market
    • 4.4.2. Market Limiters
      • 4.4.2.1. Allograft Bone Graft Substitute Market
      • 4.4.2.2. Demineralized Bone Matrix Bone Graft Substitute Market
      • 4.4.2.3. Synthetic Bone Graft Substitute Market
  • 4.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX II: COMPANY PRESS RELEASES

LIST OF CHARTS

  • Chart 1-1: Orthopedic Biomaterials Market by Segment, U.S., 2013 - 2023
  • Chart 1-2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
  • Chart 4-1: Orthopedic Bone Graft Substitute Market by Material, U.S., 2013 - 2023
  • Chart 4-2: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2016
  • Chart 4-3: Orthopedic Bone Graft Substitute Market Breakdown by Material, U.S., 2023
  • Chart 4-4: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023
  • Chart 4-5: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2016
  • Chart 4-6: Orthopedic Bone Graft Substitute Market Breakdown by Indication, U.S., 2023
  • Chart 4-7: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-8: Total Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-9: Allograft Bone Graft Substitute Market by Indication, U.S., 2013 - 2023
  • Chart 4-10: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-11: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-12: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-13: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-14: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-15: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-16: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-17: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-18: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-19: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-20: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-21: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-22: Total Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-23: Demineralized Bone Matrix Market by Indication, U.S., 2013 - 2023
  • Chart 4-24: Total Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-25: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-26: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-27: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-28: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-29: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-30: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-31: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-32: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-33: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-34: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-35: Oncology Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Chart 4-36: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-37: Synthetic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023
  • Chart 4-38: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-39: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-40: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-41: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-42: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-43: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-44: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-45: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-46: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-47: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-48: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-49: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-50: Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-51: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-52: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-53: Total Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-54: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-55: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-56: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-57: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-58: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-59: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-60: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-61: Oncology Bone Graft Substitute Market, U.S., 2013 - 2023
  • Chart 4-62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016

LIST OF FIGURES

  • Figure 1-1: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (1 of 2)
  • Figure 1-2: Orthopedic Biomaterials Market Share Ranking by Segment, U.S., 2016 (2 of 2)
  • Figure 1-3: Companies Researched in this Report, U.S., 2016
  • Figure 1-4: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (1 of 2)
  • Figure 1-5: Factors Impacting the Orthopedic Biomaterials Market by Segment, U.S. (2 of 2)
  • Figure 1-6: Recent Events in the Orthopedic Biomaterials Market, U.S., 2013 - 2016
  • Figure 1-7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 of 2)
  • Figure 1-8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 of 2)
  • Figure 1-9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 of 3)
  • Figure 3-1: Bone Graft Substitutes Products by Company (1 of 3)
  • Figure 3-2: Bone Graft Substitutes Products by Company (2 of 3)
  • Figure 3-3: Bone Graft Substitutes Products by Company (3 of 3)
  • Figure 3-4: Class 2 Device Recall Endobon Xenograft Granules
  • Figure 3-5: Class 2 Device Recall Accell Evo3c Demineralized Bone Matrix Putty
  • Figure 3-6: Class 2 Device Recall AlloFuse DBM Putty 5cc
  • Figure 3-7: Class 2 Device Recall MicroFuse Bone Void Filler
  • Figure 3-8: Class 2 Device Recall Grafton
  • Figure 3-9: Class 2 Device Recall Optimum Expanse
  • Figure 3-10: Class 2 Device Recall Integra Mozaik
  • Figure 3-11: An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix
  • Figure 3-12: Cerament Treatment of Fracture Defects (CERTiFy)
  • Figure 3-13: Synthetic Bone Graft Substitute vs. Autologous Spongiosa in Revision Anterior Cruciate Ligament Reconstruction
  • Figure 3-14: Assessment of nanOss Bioactive 3D in the Posterolateral Spine
  • Figure 3-15: AttraX® Putty vs. Autograft in XLIF®
  • Figure 3-16: Evaluation of Fusion Rate Using K2M VESUVIUS® Demineralized Fibers With K2M EVEREST® Spinal System
  • Figure 3-17: Clinical Evaluation of GENEX® DS in Instrumented Posterolateral Fusion
  • Figure 3-18: Efficacy and Safety of SurgiFill™ on Spinal Fusion
  • Figure 3-19: Evaluation of DTRAX Graft in Patients With Cervical Degenerative Disc Disease
  • Figure 3-20: Comparison of nanOss Bioactive With Autograft and Bone Marrow Aspirate to Autograft in the Posterolateral Spine
  • Figure 3-21: Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™
  • Figure 4-1: Units per Procedure by Indication, Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-2: Orthopedic Bone Graft Substitute Market by Material, U.S., 2013 - 2023 (US$M)
  • Figure 4-3: Orthopedic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023 (US$M)
  • Figure 4-4: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-5: Total Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-6: Allograft Bone Graft Substitute Market by Indication, U.S., 2013 - 2023
  • Figure 4-7: Total Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-8: Cervical Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-9: Thoracolumbar Spine Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-10: Total Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-11: Non-Union Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-12: Fresh Fracture Trauma Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-13: Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-14: Hip Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-15: Knee Large Joint Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-16: Foot Reconstruction Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-17: Craniomaxillofacial Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-18: Oncology Allograft Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-19: Total Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-20: Demineralized Bone Matrix Market (with Carriers), U.S., 2013 - 2023
  • Figure 4-21: Demineralized Bone Matrix Market (without Carriers), U.S., 2013 - 2023
  • Figure 4-22: Demineralized Bone Matrix Market by Indication, U.S., 2013 - 2023
  • Figure 4-23: Total Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-24: Cervical Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-25: Thoracolumbar Spine Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-26: Total Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-27: Non-Union Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-28: Fresh Fracture Trauma Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-29: Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-30: Hip Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-31: Knee Large Joint Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-32: Foot Reconstruction Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-33: Craniomaxillofacial Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-34: Oncology Demineralized Bone Matrix Market, U.S., 2013 - 2023
  • Figure 4-35: Total Orthopedic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-36: Synthetic Bone Graft Substitute Market by Indication, U.S., 2013 - 2023
  • Figure 4-37: Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-38: Cervical Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-39: Thoracolumbar Spine Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-40: Total Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-41: Non-Union Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-42: Fresh Fracture Trauma Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-43: Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-44: Hip Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-45: Knee Large Joint Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-46: Foot Reconstruction Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-47: Craniomaxillofacial Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-48: Oncology Synthetic Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-49: Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-50: Cervical Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-51: Thoracolumbar Spine Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-52: Total Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-53: Non-Union Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-54: Fresh Fracture Trauma Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-55: Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-56: Hip Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-57: Knee Large Joint Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-58: Foot Reconstruction Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-59: Craniomaxillofacial Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-60: Oncology Bone Graft Substitute Market, U.S., 2013 - 2023
  • Figure 4-61: Drivers and Limiters, Orthopedic Bone Graft Substitute Market, U.S., 2016
  • Figure 4-62: Leading Competitors, Orthopedic Bone Graft Substitute Market, U.S., 2016
  • Figure 6-1: Press Release Summary
Back to Top